List of bibliographic references
Number of relevant bibliographic references: 5.
List of associated KwdEn.i
Nombre de documents | Descripteur |
2 | Adult |
2 | Female |
2 | Follow-Up Studies |
2 | Humans |
2 | Male |
1 | Adolescent |
1 | Aged |
1 | Antigens, CD (metabolism) |
1 | Antiviral Agents (adverse effects) |
1 | Antiviral Agents (therapeutic use) |
1 | Combined Modality Therapy |
1 | Drug Administration Schedule |
1 | Drug Therapy, Combination |
1 | Europe |
1 | Flow Cytometry (standards) |
1 | Genotype |
1 | Hepacivirus (genetics) |
1 | Hepatitis C, Chronic (complications) |
1 | Hepatitis C, Chronic (drug therapy) |
1 | High-Throughput Nucleotide Sequencing (methods) |
1 | Immunophenotyping |
1 | Interferon-alpha (therapeutic use) |
1 | Leukemia, Lymphocytic, Chronic, B-Cell (pathology) |
1 | Leukemia, Lymphocytic, Chronic, B-Cell (therapy) |
1 | Linear Models |
1 | Liver Cirrhosis (virology) |
1 | Middle Aged |
1 | Multivariate Analysis |
1 | Neoplasm Staging |
1 | Neoplasm, Residual (diagnosis) |
1 | Neoplasm, Residual (genetics) |
1 | Neoplasm, Residual (metabolism) |
1 | Oligopeptides (adverse effects) |
1 | Oligopeptides (therapeutic use) |
1 | Polyethylene Glycols (therapeutic use) |
1 | Prognosis |
1 | Prospective Studies |
1 | Recombinant Proteins (therapeutic use) |
1 | Ribavirin (therapeutic use) |
1 | Treatment Outcome |
1 | Young Adult |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "C. Moreno"
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i \
-Sk "C. Moreno" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Allemagne
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= C. Moreno
}}
| This area was generated with Dilib version V0.6.33. Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 | |